The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Distinguishing between cancer-related mutations and clonal hematopoiesis using cell-free RNA (cfRNA) expression levels in a machine learning model.
 
Maher Albitar
Employment - Genomic Testing Cooperative
Leadership - Genomic Testing Cooperative
Stock and Other Ownership Interests - Genomic Testing Cooperative
Patents, Royalties, Other Intellectual Property - Multiple patents on methods in diagnostics
Travel, Accommodations, Expenses - Genomic Testing Cooperative
 
Hong Zhang
Stock and Other Ownership Interests - Genomic Testing Cooperative
Consulting or Advisory Role - Genomic Testing Cooperative
 
Andrew Ip
Stock and Other Ownership Interests - Cota Healthcare; Merck (I)
Honoraria - MJH Life Sciences; MJH Life Sciences
Consulting or Advisory Role - Secura Bio; TG Therapeutics
Speakers' Bureau - AstraZeneca; Seagen
(OPTIONAL) Uncompensated Relationships - COTA; Genomic Testing Cooperative
 
Jeffrey Estella
Employment - Genomic Testing Cooperative
Stock and Other Ownership Interests - Genomic Testing Cooperative
 
Ahmad Charifa
Employment - Genomic Testing Cooperative
Stock and Other Ownership Interests - Genomic Testing Cooperative
 
Wanlong Ma
Employment - Genomic Testing Cooperative
Stock and Other Ownership Interests - Genomic Testing Cooperative
 
Arash Mohtashamian
Employment - Genomic Testing Cooperative
Stock and Other Ownership Interests - Genomic Testing Cooperative
 
Martin Gutierrez
Stock and Other Ownership Interests - Cota Healthcare
Speakers' Bureau - BMS; Lilly; Merck
Research Funding - Acerta Pharma (Inst); Adlai Nortye (Inst); Arcus Biosciences (Inst); Array BioPharma (Inst); Bayer (Inst); Bellicum Pharmaceuticals (Inst); BMS (Inst); Boehringer Ingelheim (Inst); Celgene (Inst); Checkpoint Therapeutics (Inst); Compass Therapeutics (Inst); Constellation Pharmaceuticals (Inst); Cullinan Oncology (Inst); Cyteir (Inst); Daiichi Sankyo Company (Inst); Eisai (Inst); EMD Serono (Inst); EMD Serono (Inst); Erasca, Inc (Inst); Fate Therapeutics (Inst); Georgetown Univ. (Inst); GlaxoSmithKline (Inst); GSB Pharma (Inst); Hackensack Meridian Health (Inst); Imugene (Inst); Incyte (Inst); Incyte (Inst); Infinity Pharmaceuticals (Inst); ITeos Therapeutics (Inst); Janssen (Inst); Johnson & Johnson (Inst); KSQ Therapeutics (Inst); MedImmune (Inst); Memorial Sloan-Kettering Cancer Center (Inst); Merck (Inst); Millennium (Inst); Mirati Therapeutics (Inst); Moderna Therapeutics (Inst); NextCure (Inst); NextCure (Inst); Nimbus Therapeutics (Inst); Pfizer (Inst); Pharmacyclics (Inst); Rapa Therapeutics (Inst); Regeneron (Inst); Roche/Genentech (Inst); Sanofi (Inst); Seagen (Inst); Silenseed (Inst); Silenseed (Inst); Synlogic (Inst); Tesaro (Inst); Turning Point Therapeutics (Inst); Vedanta Biosciences (Inst); VelosBio (Inst); Verastem (Inst); Vincerx Pharma (Inst)
Travel, Accommodations, Expenses - Guardant Health
 
Andrew L Pecora
Employment - Celularity Inc; Cota Healthcare; Outcomes Matter Innovations (OMI); Regional Cancer Care Associates
Leadership - Celularity Inc; Cota Healthcare; Genetic testing cooperative (GTC); Regional Cancer Care Associates
Stock and Other Ownership Interests - Celularity Inc; Cota Healthcare; Genetic testing cooperative (GTC); Regional Cancer Care Associates
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Bristol-Myers Squibb
Speakers' Bureau - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb (Inst)
Patents, Royalties, Other Intellectual Property - Cd34 patents COTA patents
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Andre Goy
Employment - OM Pharmaceutical Industries; Regional Cancer Care Associates
Leadership - COTA; Genomic Testing Cooperative; Resilience Care
Stock and Other Ownership Interests - Alloplex Biotherapeutics Inc; COTA; Genomic Testing Cooperative; Resilience Care
Honoraria - Alloplex Biotherapeutics Inc; Clinical Advances in Hematology & Oncology; Janssen Biotech; Kite, a Gilead company; Vincerx Pharma
Consulting or Advisory Role - Clinical Advances in Hematology & Oncology; Janssen; Kite, a Gilead company (Inst); Physicans' Education Resource; Vincera Pharma/Vincerx Pharma
Speakers' Bureau - Bristol-Myers Squibb/Celgene
Research Funding - Acerta Pharma (Inst); AstraZeneca (Inst); Bristol Meyers; Celgene (Inst); Constellation Pharmaceuticals; Genentech/Roche (Inst); Infinity Pharmaceuticals (Inst); Infinity/Verastem (Inst); Janssen (Inst); Karyopharm Therapeutics (Inst); Kite/Gilead (Inst); MorphoSys; Pharmacyclics (Inst); Seagen; Verastem; Verastem
Travel, Accommodations, Expenses - Physicans' Education Resource
Other Relationship - AstraZeneca